Aspergillosis natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Changes made per Mahshid's request)
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Aspergillosis}}
{{Aspergillosis}}
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}}
{{CMG}} {{AE}} {{YD}}; {{HL}}; {{SSK}}
 
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


==Overview==
==Overview==
With treatment, people with allergic aspergillosis usually gets better over time. Relapse is common and needs repeated treatment. It could be fatal if un-responsive to treatment. Prognosis also depends on the patients immune status.
Following transmission, the majority of patients do not develop any clinical manifestations. The incubation of ''Aspergillosis'' is highly dependent on the host immune factors. The incubation period may range from a few days to years, during which the host is asymptomatic. Among immunocompetent hosts, ''Aspergillosis'' may result in a localized pulmonary infection, allergic bronchopulmonary aspergillosis, or allergic ''Aspergillus'' sinusitis. Among immunocompromised hosts, ''Aspergillosis'' progresses faster and has a more invasive course. If left untreated, aspergillosis in immunocompromised patients often progresses, and patients report worsening fever, chest pain, and hemoptysis. Invasive aspergillosis eventually disseminates to non-pulmonary organs and results in life-threatening complications.


==Natural History==
==Natural History==
*Following transmission, the majority of patients do not develop any clinical manifestations.
*The incubation of ''Aspergillosis'' is highly dependent on the host immune factors. The incubation period may range from a few days to years, during which the host is asymptomatic.
===Immunocompetent Host===
*Among immunocompetent hosts, ''Aspergillosis'' may result in a localized pulmonary infection, allergic bronchopulmonary aspergillosis, or allergic ''Aspergillus'' sinusitis.
*Clinical manifestations may vary depending on the clinical syndrome. In allergic aspergillosis, patients often develop mild symptoms of asthma or sinusitis with productive cough, wheezing, and stuffiness.
*Patients with chronic aspergillosis, however, may develop chronic fever, constitutional symptoms (such as weight loss), dyspnea, and occasionally hemoptysis. If left untreated, patients who develop chronic cavitary aspergillosis may then progress to develop chronic fibrosing aspergillosis and respiratory failure.
===Immunocompromised Host===
*Among immunocompromised hosts, ''Aspergillosis'' progresses faster and has a more invasive course.
*Immunocompromised patients are at higher risk of developing invasive aspergillosis, aspergilloma, chronic necrotizing aspergillosis, and cutaneous aspergillosis secondary to lung aspergillosis.
*If left untreated, aspergillosis in immunocompromised patients often progresses, and patients report worsening [[fever]], [[chest pain]], and [[hemoptysis]].
*Invasive aspergillosis eventually disseminates to non-pulmonary organs and results in life-threatening complications.
==Complications==
==Complications==
* [[Amphotericin B]] can cause kidney damage and unpleasant side effects such as [[fever]] and [[chills]]
Complications of aspergillosis includes the following:
* [[Bronchiectasis]] (permanent scarring and enlargement of the small sacs in the lungs)
* [[Aortitis]]
* Invasive lung disease can cause massive bleeding from the lung
* [[Acute kidney injury]]
* [[Mucus]] plugs in the airways
* [[Liver disease|Hepatic injury]]
* Permanent airway blockage
* [[Bronchiectasis]]
* [[Hemorrhage]]
* [[Respiratory failure]]
* [[Acute respiratory distress syndrome]]
* [[Encephalitis]]
* [[Asthma|Asthma exacerbation]]
* [[Atelectasis]]
* [[Pulmonary fibrosis|Progressive pulmonary fibrosis]]
* [[Osteomyelitis]]
* Cardiothoracic aspergillosis
* Cardiac aspergillosis
* Valvular fungus ball
* [[Endocarditis]]
* [[Lacrimal canaliculitis]]
 
==Prognosis==
==Prognosis==
*The prognosis of aspergillosis varies according to the clinical syndrome.
*Allergic bronchopulmonary aspergillosis and allergic ''Aspergillus'' sinusitis generally have a good prognosis and rarely result in mortality.
*In contrast, the prognosis for either invasive aspergillosis or chronic necrotizing pulmonary aspergillosis is generally poor. The mortality rate may be as high as 40% to 90%.<ref name="CDC">Definition of Aspergillosis -  Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/fungal/diseases/aspergillosis/statistics.html Accessed on Feb 8 2016</ref>
*Poor prognostic factors include:
:*Diagnosis of invasive aspergillosis
:*Age extremes
:*Severe immunosuppression
:*Extensive degree of invasion at diagnosis


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{Mycoses}}


[[Category:Fungal diseases]]
[[Category:Fungal diseases]]
[[Category:Infectious disease]] 
[[Category:Needs content]]
[[de:Aspergillose]]
[[fr:Aspergillose]]
[[hr:Aspergiloza]]
[[nl:Aspergillose]]
[[pl:Aspergiloza]]
[[pt:Aspergilose]]
[[uk:Аспергільоз]]
{{WH}}
{{WS}}

Latest revision as of 17:01, 18 September 2017

Aspergillosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Aspergillosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Future or Investigational Therapies

Case Studies

Case #1

Aspergillosis natural history, complications and prognosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Aspergillosis natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Aspergillosis natural history, complications and prognosis

CDC on Aspergillosis natural history, complications and prognosis

Aspergillosis natural history, complications and prognosis in the news

Blogs on Aspergillosis natural history, complications and prognosis

Aspergillosis

Risk calculators and risk factors for Aspergillosis natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Haytham Allaham, M.D. [2]; Serge Korjian M.D.

Overview

Following transmission, the majority of patients do not develop any clinical manifestations. The incubation of Aspergillosis is highly dependent on the host immune factors. The incubation period may range from a few days to years, during which the host is asymptomatic. Among immunocompetent hosts, Aspergillosis may result in a localized pulmonary infection, allergic bronchopulmonary aspergillosis, or allergic Aspergillus sinusitis. Among immunocompromised hosts, Aspergillosis progresses faster and has a more invasive course. If left untreated, aspergillosis in immunocompromised patients often progresses, and patients report worsening fever, chest pain, and hemoptysis. Invasive aspergillosis eventually disseminates to non-pulmonary organs and results in life-threatening complications.

Natural History

  • Following transmission, the majority of patients do not develop any clinical manifestations.
  • The incubation of Aspergillosis is highly dependent on the host immune factors. The incubation period may range from a few days to years, during which the host is asymptomatic.

Immunocompetent Host

  • Among immunocompetent hosts, Aspergillosis may result in a localized pulmonary infection, allergic bronchopulmonary aspergillosis, or allergic Aspergillus sinusitis.
  • Clinical manifestations may vary depending on the clinical syndrome. In allergic aspergillosis, patients often develop mild symptoms of asthma or sinusitis with productive cough, wheezing, and stuffiness.
  • Patients with chronic aspergillosis, however, may develop chronic fever, constitutional symptoms (such as weight loss), dyspnea, and occasionally hemoptysis. If left untreated, patients who develop chronic cavitary aspergillosis may then progress to develop chronic fibrosing aspergillosis and respiratory failure.

Immunocompromised Host

  • Among immunocompromised hosts, Aspergillosis progresses faster and has a more invasive course.
  • Immunocompromised patients are at higher risk of developing invasive aspergillosis, aspergilloma, chronic necrotizing aspergillosis, and cutaneous aspergillosis secondary to lung aspergillosis.
  • If left untreated, aspergillosis in immunocompromised patients often progresses, and patients report worsening fever, chest pain, and hemoptysis.
  • Invasive aspergillosis eventually disseminates to non-pulmonary organs and results in life-threatening complications.

Complications

Complications of aspergillosis includes the following:

Prognosis

  • The prognosis of aspergillosis varies according to the clinical syndrome.
  • Allergic bronchopulmonary aspergillosis and allergic Aspergillus sinusitis generally have a good prognosis and rarely result in mortality.
  • In contrast, the prognosis for either invasive aspergillosis or chronic necrotizing pulmonary aspergillosis is generally poor. The mortality rate may be as high as 40% to 90%.[1]
  • Poor prognostic factors include:
  • Diagnosis of invasive aspergillosis
  • Age extremes
  • Severe immunosuppression
  • Extensive degree of invasion at diagnosis

References

  1. Definition of Aspergillosis - Centers for Disease Control and Prevention (CDC) http://www.cdc.gov/fungal/diseases/aspergillosis/statistics.html Accessed on Feb 8 2016